Insider filing · ROIV

Vivek Ramaswamy sold $10.1M of Roivant Sciences (ROIV)

Executed May 6 2025, disclosed May 8 2025, 2 days later.

Returns are measured on stock purchases only.

VR Vivek Ramaswamy 10% owner profile →

Vivek Ramaswamy (10% owner) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $67.9M of ROIV (3,103,745 sh across 3 lots, as filed), executed Dec 11 2025. The median gap between execution and disclosure was 2 days.

ROIV Roivant Sciences Ltd. ROIV · Healthcare · 75 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→